Trade Straumann Holding AG - STMN CFD

About Straumann Holding AG

Straumann Holding AG is a Switzerland-based company active in the field of implant and restorative dentistry and oral tissue regeneration. In collaboration with clinics, research institutes and universities, the Group researches and develops implants, instruments, computer-aided design/manufacturing (CAD/CAM) prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann Holding AG also offers a range of services to the dental profession worldwide, including training and education, provided in collaboration with the International Team for Implantology (ITI). Its products and services are available in a number of countries through the Group’s headquarters and through a network of subsidiaries and technology partners located in Europe, North America, the Asia/Pacific region and in Latin America, including Dental Wings Inc based in Canada and Createch Medical SL based in Spain.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Straumann Holding AG revenues increased 42% to SF2.02B. Net income applicable to common stockholders increased from SF91.3M to SF396.1M. Revenues reflect Sales NAM segment increase of 39% to SF613.6M, Sales APAC segment increase of 39% to SF388.8M, Sales LATAM segment increase of 44% to SF129.7M, Others segment increase of 35% to SF666.9M, United States segment increase of 30% to SF516.9M.